Cancer Family
Anaplastic Malignant Neoplasm
CI-CAN-00000065Explore in graph →
546 active trials4 approved drugs57 evidence items
- NCIt
- C36025
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000065Explore in graph →
Clinical trials
2,019 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (324)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03557372 | Mathematical Model-Adapted Radiation In Glioblastoma | completed | N/A | 14 | Dana-Farber Cancer InstituteOTHER | 1 | Oct 26, 2023 | clinicaltrials |
| NCT06017063 | Coaching for Coping in Glioblastoma Patients and Caregivers and Its Association With Compliance to TTFields(COCOON) | not yet recruiting | N/A | 275 | University Hospital TuebingenOTHER | 0 | Aug 30, 2023 | clinicaltrials |
| NCT03055208 | Early Stereotactic Gamma Knife Radiosurgery to Residual Tumor After Surgery of Newly Diagnosed Glioblastoma(Gamma-GBM) | suspended | N/A | 50 | Universitätsmedizin MannheimOTHER | 1 | May 11, 2023 | clinicaltrials |
| NCT05410301 | Golden Halo, Static Magnetic and Electric Field Device, in Recurrent Glioblastoma | withdrawn | N/A | 0 | Varun Monga, MDOTHER | 1 | Apr 21, 2023 | clinicaltrials |
| NCT05811793 | Efficacy and Safety of SCAI of Bevacizumab Combined With IC of Tislelizumab in the Treatment of Recurrent Glioblastoma. | unknown | N/A | 36 | Second Affiliated Hospital of Nanchang UniversityOTHER | 0 | Apr 13, 2023 | clinicaltrials |
| NCT05793021 | FKBP51s: a New Molecular Biomarker for Glioblastoma? Pre- and Post-operative Blood Levels Evaluation of FKBP51s Protein and Correlation With MRI Phenotype | unknown | N/A | 70 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Mar 31, 2023 | clinicaltrials |
| NCT04630379 | Early Integration of Palliative Care Using the BEACON PROQOL in Patients With High Grade Glioma and Their Caregivers | completed | N/A | 16 | Mayo ClinicOTHER | 1 | Mar 20, 2023 | clinicaltrials |
| NCT05772741 | Grafts of GSCs Into Brain Organoids for Testing Anti-invasion Drugs(2253) | unknown | N/A | 160 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Mar 16, 2023 | clinicaltrials |
| NCT03956706 | Study of Stereotactic Radiosurgery to the Subventricular Zone in Malignant Gliomas | withdrawn | N/A | 0 | Northwell HealthOTHER | 1 | Mar 15, 2023 | clinicaltrials |
| NCT02296580 | A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM) | completed | N/A | 37 | Nativis, Inc.INDUSTRY | 2 | Feb 2, 2023 | clinicaltrials |
| NCT03276286 | Nativis Voyager for Newly Diagnosed GBM(NAT109) | completed | N/A | 37 | Nativis, Inc.INDUSTRY | 1 | Feb 2, 2023 | clinicaltrials |
| NCT01954576 | NovoTTF Therapy in Treating Patients With Recurrent Glioblastoma Multiforme | terminated | N/A | 21 | University of FloridaOTHER | 1 | Oct 31, 2022 | clinicaltrials |
| NCT05539339 | Personalized Trial in ctDNA-level-relapse Glioblastoma | unknown | N/A | 20 | Henan Provincial People's HospitalOTHER | 1 | Sep 27, 2022 | clinicaltrials |
| NCT05512195 | Safety and Efficacy of a New Approach to Delineating Clinical Target Volume of Glioblastoma(GBM) | unknown | N/A | 70 | Zhongnan HospitalOTHER | 0 | Aug 23, 2022 | clinicaltrials |
| NCT04596930 | MR-guided LITT Therapy in Patients With Primary Irresectable Glioblastoma(EMITT) | completed | N/A | 15 | Radboud University Medical CenterOTHER | 1 | Aug 9, 2022 | clinicaltrials |
| NCT05099068 | Profiling Program of Cancer Patients With Sequential Tumor and Liquid Biopsies (PLANET)(PLANET) | unknown | N/A | 500 | Centre Leon BerardOTHER | 1 | Jul 5, 2022 | clinicaltrials |
| NCT05399524 | Functional and Ultrasound Guided Resection of Glioblastoma(FUTURE-GB) | unknown | N/A | 357 | University of OxfordOTHER | 1 | Jun 1, 2022 | clinicaltrials |
| NCT03390569 | Exercise in Patients With Glioblastoma | completed | N/A | 54 | University Health Network, TorontoOTHER | 1 | Apr 14, 2022 | clinicaltrials |
| NCT02359097 | Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With Glioblastoma | completed | N/A | 29 | OHSU Knight Cancer InstituteOTHER | 1 | Mar 17, 2022 | clinicaltrials |
| NCT04516733 | Precoce Medical Care by the Mobil Support for Patients With Glioblastoma(GLIOSUPPORT) | completed | N/A | 35 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 1 | Mar 14, 2022 | clinicaltrials |
| NCT01925573 | Optune(NOVOTTF-100A)+ Bevacizumab+ Hypofractionated Stereotactic Irradiation Bevacizumab-Naive Recurrent Glioblastoma (GCC 1344) | terminated | N/A | 7 | University of Maryland, BaltimoreOTHER | 1 | Feb 3, 2022 | clinicaltrials |
| NCT02379572 | Impact of iMRI on the Extent of Resection in Patients With Newly Diagnosed Glioblastomas | completed | N/A | 315 | University Hospital TuebingenOTHER | 1 | Oct 22, 2021 | clinicaltrials |
| NCT02076152 | FMISO PET Study of Glioblastoma | completed | N/A | 11 | Massachusetts General HospitalOTHER | 1 | Jul 30, 2021 | clinicaltrials |
| NCT03787056 | Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients(ONCOPRO) | recruiting | N/A | 410 | Hospices Civils de LyonOTHER | 1 | Jul 16, 2021 | clinicaltrials |
| NCT04856852 | Iodine-125 Brachytherapy Together With Chemotherapy in Patients With Newly Diagnosed Glioblastoma(IBCNG) | unknown | N/A | 84 | The Affiliated Hospital of Qingdao UniversityOTHER | 0 | Jun 29, 2021 | clinicaltrials |
| NCT01754350 | Calorie-restricted, Ketogenic Diet and Transient Fasting During Reirradiation for Patients With Recurrent Glioblastoma(ERGO2) | completed | N/A | 50 | Johann Wolfgang Goethe University HospitalOTHER | 1 | Jun 2, 2021 | clinicaltrials |
| NCT04902586 | Effect of Radiotherapy Concurrent of TTFields in Patients With Glioblastoma(ECTG001) | unknown | N/A | 30 | Zhongnan HospitalOTHER | 1 | May 26, 2021 | clinicaltrials |
| NCT04790097 | FET-PET Directed Simultaneous In-field Boost for Primary GBM(dualFETboost) | completed | N/A | 17 | Prof. Franciszek Lukaszczyk Memorial Oncology CenterOTHER | 1 | May 6, 2021 | clinicaltrials |
| NCT00536601 | High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors | completed | N/A | 174 | Roswell Park Cancer InstituteOTHER | 1 | Apr 22, 2021 | clinicaltrials |
| NCT00400322 | Efficacy and Safety of Valcyte® as an add-on Therapy in Patients With Malignant Glioblastoma and Cytomegalovirus (CMV) Infection | completed | N/A | 42 | Karolinska InstitutetOTHER | 1 | Mar 1, 2021 | clinicaltrials |
| NCT02904525 | Glioblastoma: Validation and Comparison Between Primary Tumor and Its Murine Model(XENOGBM) | unknown | N/A | 20 | Andreas HottingerOTHER | 1 | Jan 27, 2021 | clinicaltrials |
| NCT04588454 | 18F-PSMA PET/CT for Visualization of Glioblastoma Multiforme(PSMA-GBM) | unknown | N/A | 5 | Radboud University Medical CenterOTHER | 1 | Jan 27, 2021 | clinicaltrials |
| NCT04717999 | Pilot Study of NKG2D CAR-T in Treating Patients With Recurrent Glioblastoma | unknown | N/A | 20 | UWELL BiopharmaINDUSTRY | 0 | Jan 22, 2021 | clinicaltrials |
| NCT04689087 | A Prospective, Open-label, Single-arm Clinical Study | unknown | N/A | 40 | Sun Yat-sen UniversityOTHER | 1 | Dec 30, 2020 | clinicaltrials |
| NCT03353896 | NovoTTF-200A Device in Treating Patients With Newly Diagnosed High Risk Oligodendroglioma | withdrawn | N/A | 0 | University of Southern CaliforniaOTHER | 1 | Dec 10, 2020 | clinicaltrials |
| NCT03903419 | Feasibility Study of 68Ga-PSMA PET-CT and 18F-FDOPA PET-CT in Glioblastoma's Patients(PAraDiGM) | unknown | N/A | 16 | Centre Leon BerardOTHER | 1 | Oct 14, 2020 | clinicaltrials |
| NCT01987830 | Bevacizumab w / Temozolomide PET & Vascular MRI For GBM | completed | N/A | 13 | Massachusetts General HospitalOTHER | 1 | Sep 4, 2020 | clinicaltrials |
| NCT04488783 | Potentiation of Chemotherapy in Brain Tumors by Zinc | unknown | N/A | 30 | Sheba Medical CenterOTHER_GOV | 1 | Jul 28, 2020 | clinicaltrials |
| NCT01813877 | Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma | completed | N/A | 37 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jul 27, 2020 | clinicaltrials |
| NCT03115138 | Evaluation of Circulating Tumor DNA as a Theranostic Marker in the Management of Glioblastomas.(Bi-GLAM) | terminated | N/A | 19 | Centre Hospitalier Universitaire, AmiensOTHER | 1 | Jul 15, 2020 | clinicaltrials |
| NCT02431572 | A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy | completed | N/A | 11 | Massachusetts General HospitalOTHER | 1 | Apr 28, 2020 | clinicaltrials |
| NCT01165671 | Carbon Ion Radiotherapy for Primary Glioblastoma(CLEOPATRA) | completed | N/A | 100 | University Hospital HeidelbergOTHER | 1 | Apr 3, 2020 | clinicaltrials |
| NCT03739333 | Early Diagnosis of Pseudoprogression Using 11C-Methionine PET-MRI After Concomitant Radiochemotherapy Treatment for Glioblastoma.(TIGRE) | unknown | N/A | 40 | Hospices Civils de LyonOTHER | 1 | Feb 13, 2020 | clinicaltrials |
| NCT00014235 | Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies | completed | N/A | 160 | Fred Hutchinson Cancer CenterOTHER | 3 | Jan 21, 2020 | clinicaltrials |
| NCT00003196 | Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma | completed | N/A | 63 | Fred Hutchinson Cancer CenterOTHER | 3 | Dec 27, 2019 | clinicaltrials |
| NCT01540513 | PET/CT Evaluation of Primary and Metastatic Brain Tumors With a Novel Radioiodinated Phospholipid Ether Analogue I-NM404 | completed | N/A | 12 | University of Wisconsin, MadisonOTHER | 1 | Dec 2, 2019 | clinicaltrials |
| NCT03843814 | Pilot Study Using Amide Proton Transfer Magnetic Resonance Imaging Distinguishing Glioma | terminated | N/A | 13 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Nov 26, 2019 | clinicaltrials |
| NCT02652715 | Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma | completed | N/A | 29 | Mayo ClinicOTHER | 1 | Nov 15, 2019 | clinicaltrials |
| NCT00856388 | Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders | completed | N/A | 62 | Roswell Park Cancer InstituteOTHER | 1 | Nov 13, 2019 | clinicaltrials |
| NCT02374255 | Improving Goals of Care Discussion in Advanced Cancer Patients | completed | N/A | 265 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Oct 1, 2019 | clinicaltrials |
Data updated 22 days agoSource updated Oct 26, 2023source: clinicaltrials